Actively Recruiting
Erythrocytapheresis for Chronic Mountain Sickness
Led by Third Military Medical University · Updated on 2026-04-02
112
Participants Needed
1
Research Sites
219 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study aims to explore the efficacy and safety of erythrocytapheresis in chronic mountain sickness
CONDITIONS
Official Title
Erythrocytapheresis for Chronic Mountain Sickness
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Continuous residence at 2500 meters above sea level or higher for at least 1 year with no travel to low-altitude areas in the past 3 months
- Hemoglobin level of at least 210 g/L for men or 190 g/L for women
- Presence of at least one symptom or sign such as headache, dizziness, dyspnea, palpitations, sleep disturbances, fatigue, localized cyanosis, burning sensation in palms/soles, venous dilatation, muscle/joint pain, loss of appetite, poor concentration, or memory changes
- Chronic Mountain Sickness total score of 6 or higher
- Written informed consent provided by the patient or their legal representative
You will not qualify if you...
- Hematocrit less than 60%
- Erythrocytosis caused by polycythemia vera, dehydration, cyanotic congenital heart disease, chronic obstructive pulmonary disease, or other blood or cancer-related conditions
- Active pneumonia, pulmonary embolism, or severe organ dysfunction including heart, liver, or kidney failure
- Contraindications to study procedures such as impaired consciousness, pneumothorax, severe arrhythmia, or significant coagulation disorders
- Receipt of CMS-specific treatments like phlebotomy, erythrocytapheresis, or targeted drugs within the last 6 months
- Pregnancy, breastfeeding, or planning pregnancy within 1 year
- Terminal illness with life expectancy less than 6 months
- Current participation in other clinical trials
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NO.953 Hospital
Xigazê, Tibet, China, 857000
Actively Recruiting
Research Team
J
Jieru Guo
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here